Juvenile Idiopathic Arthritis

Largest, most representative JIA data registry available for licensing, analytics, and collaboration

Research-Grade RWD in JIA

Unmet Need

Disease with no cure

With no cure for JIA, early diagnosis and effective treatment are the best ways to help reduce damaging effects and improve patients’ quality of life.

Deep Clinical Data

4,700+*

JIA patients followed prospectively with deep clinical, lab, and other linked data

*Counts are based on Q2 2023 registry release

Analytics & Modeling

65,500+*

JIA patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes

Why OM1 JIA?

Sample Use Cases

» Feasibility	» Comparative Effectiveness
» Passive Safety	» Natural History

Webinar: Real-World Data for R&D for Autoimmune & Chronic Diseases

Infosheet

Learn about the OM1 JIA Registry:

Abstracts & Publications

Poster (ISPOR EU 2019): Patient Characteristics and Management Of Juvenile Idiopathic Arthritis (JIA) In a Large, Representative Real-World Cohort

Request a Meeting

Name*
First Last
Company Name*
Job Title*
Email*
Message*
Phone
This field is for validation purposes and should be left unchanged.